Clinical Trial: Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Immunogenicity and Safety of Fractional Doses of Sanofi Pasteur's Inactivated Poliomyelitis Vaccine Administered Intradermally vs Full Doses of Inactivated Same as current

Current Secondary Outcome: Immunogenicity: To assess and describe in each group the immunogenicity of the study vaccines one month after the three-dose primary vaccination Safety: To describe in each group the safety after each dose of the study vaccines [ Time Frame: 1 Month post-vaccination ]

Original Secondary Outcome: Same as current

Information By: Sanofi

Dates:
Date Received: January 17, 2008
Date Started: January 2008
Date Completion:
Last Updated: January 20, 2014
Last Verified: January 2014